Infertility can be a challenging and deeply personal experience for both women and men. It often involves more than a single medical factor and may be influenced by hormonal changes, tissue health, immune balance, age-related processes, and overall well-being.
Today, IVF and ICSI remain the foundation of modern fertility treatment, and these methods play a central role in helping many couples move closer to parenthood.
At Swiss Medica, regenerative and stem cell–based therapies are considered a complementary and supportive option within infertility care. They are not intended to replace standard reproductive treatments, but rather to be integrated into an individualized medical strategy, when appropriate, alongside established methods.
Supporting Female Reproductive Health
In women, regenerative approaches are explored for their potential to support ovarian function, endometrial health, and the overall biological environment involved in reproduction.
These therapies may be considered in selected cases such as age-related changes, reduced ovarian reserve, or conditions affecting uterine tissue — always following a thorough medical evaluation.
How This Approach Fits into Fertility Treatment
Regenerative therapies may be considered at different stages of fertility care, always in coordination with standard reproductive medicine:
- Before IVF / ICSI, to help optimize the biological environment that supports reproductive function, including tissue health and inflammatory balance.
- Between IVF / ICSI cycles, when additional medical support may be considered as part of a broader, individualized plan.
- After IVF / ICSI, as supportive care in selected situations, depending on medical indications and patient goals.
Each case is assessed individually, taking into account medical history, diagnostic findings, previous fertility treatments, and overall health.
Addressing Male Fertility as Part of the Whole Picture
Male infertility is an important and sometimes overlooked aspect of reproductive care. At Swiss Medica, male fertility factors may be discussed as part of a broader reproductive context, particularly when couples are exploring fertility-related concerns.
Regenerative approaches are studied for their potential role in supporting testicular tissue function and spermatogenesis, with the aim of complementing established andrological and reproductive treatments.
As with female infertility, these therapies are considered only when medically appropriate and as part of a coordinated care plan.
Guiding You with Compassion and Clarity
Every patient’s situation is unique and infertility treatment is often an emotional journey as well as a medical one.
Swiss Medica’s role is to offer careful guidance, coordinated care, and a respectful, patient-centered approach, working in alignment with standard reproductive medicine to support each patient’s path forward.
Talk to our team
If you’re exploring supportive regenerative options alongside IVF/ICSI or would like to explore whether Swiss Medica’s regenerative options may be relevant for your case, feel free to contact us – we’ll be happy to connect you with their team.
